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Abstract Background: 
Objectives: This study evaluated the weight trajectories of Roux-en-Y gastric bypass (RYGB) 
patients and identified the distinct clinical, behavioral, and demographic features of patients by 
trajectory. 
Setting: Data from 2918 RYGB patients from a comprehensive medical center between January 
2004 and November 2016 were included. 
Methods: This retrospective, observational study used data for RYGB patients up to 7 years 
postsurgery. Group-based trajectory models were fitted for percentage weight change. Variables 
evaluated by trajectory included age, sex, diagnoses, medications, smoking, presurgical body mass 
index, preoperative weight loss, and early postoperative weight loss. 
Results: Of 3215 possible patients, 2918 (90.8%) were included (mean age = 46.2 ± 11.2 yr, 
body mass index = 46.9 ± 7.9 kg/m 2 at the time of surgery). Three weight change trajectories 
were identified (above average, average, and below average). Mean percentage weight change at 
the nadir for the above average group was −42.85% ± 5.7% compared with −31.57% ± 5.0% in 
the average group and −22.74% ± 5.7% in the below average group. Compared with the above 
average group, the below average group was more likely to be male (odds ratio [OR] = 2.40, 
P < .0001) and have diabetes (noninsulin users, OR = 2.08, P < .0001), but less likely to have 
a smoking history (OR = .62, P = .0007) or take sleep medications (OR = .50, P = .005). Below 
average group patients had a lower BMI at the time of surgery (OR = .96, P < .0001). Lower 
initial weight loss postsurgery was associated with a greater chance of a poorer weight outcomes 
(OR = 1.64, P < .0001). 
Conclusion: Select clinical, demographic, and behavioral factors may increase or decrease the 
chance for better weight loss after RYGB. (Surg Obes Relat Dis 2018;xxx:xxx–xxx.) © 2018 
American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved. 
Keywords: Roux-en-Y Gastric bypass; Weight loss trajectories; Predictors 
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For many patients with obesity, weight loss surgery con- 1 
veys durable benefits that span improvements in physi- 2 
cal and mental health, longevity, and quality of life [1– 3 
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6] . However, weight change trajectories after surgery are 4 
heterogeneous [1] . In 2013, Courcoulas et al. [1] mod- 5 
eled weight change trajectories of surgery patients through 6 
3 years postoperatively and found that approximately 23% 7 
of Roux-en-Y gastric bypass (RYGB) patients did not 8 
achieve or sustain > 25% total weight loss. 9 
In the era of precision medicine [7] , better understand- 10 
ing the demographic and clinical features of weight loss 11 
surgery patients who experience poorer outcomes would 12 
help to guide clinical care. To date, body mass index (BMI) 13 
at the time of surgery and age are consistently associ- 14 
ated with weight change postoperatively [8–12] . Certain 15 
personality disorders or traits, eating pathology and psy- 16 
chiatric disorders, diabetes status, and preoperative weight 17 
loss may also relate to postoperative weight loss, though 18 
findings are less consistent regarding these relationships 19 
[8,9,13–17] . Wood and colleagues [16] found preoperative 20 
insulin use, history of smoking, and a high number of pre- 21 
scribed medications to relate to better long-term weight 22 
loss, while hyperlipidemia was associated with poorer out- 23 
comes. Finally, early postoperative weight loss (initial 3–6 24 
mo) is associated with greater weight loss 2 years after 25 
RYGB [18] . 26 
This study’s objective was to evaluate the determinants 27 
of weight change trajectories in a cohort of RYGB pa- 28 
tients followed for 7 years postsurgery. Specifically, this 29 
study aimed to (1) replicate weight loss trajectory model- 30 
ing conducted previously [1] but for a longer timeframe 31 
and (2) compare the demographic, behavioral, and clinical 32 
factors associated with the weight-change trajectories, in- 33 
cluding preoperative and early postoperative weight loss, 34 
diagnoses, and medication use. 35 
Methods 36 
Participants 37 
De-identified electronic health record (EHR) data were 38 
obtained for patients who completed weight loss surgery 39 
from January 2004 to November 2016 at a large, ru- 40 
ral, comprehensive medical center. Inclusion criteria were 41 
as follows: (1) completion of primary RYGB, and (2) 42 
weight data available in the EHR preoperatively and post- 43 
operatively (up to year 7). Patients who were < 1 year 44 
postsurgery were excluded. The preoperative program for 45 
weight loss surgery involves a 6- to 12-month multidisci- 46 
plinary curriculum with the goal of 10% weight loss [19] . 47 
Postoperatively, patients are scheduled for follow-up visits 48 
1 and 2 weeks after surgery; 2, 5, 8, and 12 months; and 49 
yearly thereafter. 50 
Outcome measures 51 
The primary study outcome was the percentage of ini- 52 
tial weight change [1] , measured longitudinally through 53 
7 years. Weights were collected from the EHR from all 54 
encounters across the health system. 55 
Demographic variables included patients’ age, sex, and 56 
race. Clinical variables collected at the time of surgery 57 
were diagnoses (i.e., mood disorders, osteoarthritis, dia- 58 
betes, nondependent drug use, hypertension, sleep disor- 59 
ders, back or soft tissue disorders, fibrosis, and dyslipi- 60 
demia as documented by International Classification of 61 
Disease code), use of certain medications and total medi- 62 
cations prescribed, and surgical BMI. 63 
Behavioral factors included history of smoking, presur- 64 
gical weight loss (time of initial consult to day of surgery), 65 
and early postoperative weight change (percentage weight 66 
change from day of surgery through postsurgery month 67 
6). 68 
Statistical analyses 69 
Descriptive statistics characterized the cohort at the time 70 
of surgery (mean and standard deviation for continuous 71 
variables and frequency for categorical variables). 72 
To account for heterogeneity of postsurgery weight 73 
change patterns, group-based trajectory models (GBTM) 74 
[20] with time as a polynomial trend (6 mo postsurgery 75 
through up to 7 yr postsurgery) were fitted for the per- Q3 76 
centage weight change from baseline. Given a minimum of 77 
1% sample inclusion per trajectory [1] , Bayesian criterion 78 
determined the best model fit. Percentage weight change 79 
up to 7 years postsurgery was plotted from postoperative 80 
month 6 for each trajectory. To identify factors associated 81 
with group membership, preoperative factors and weight Q4 82 
change within 6 months postsurgery were linked to the 83 
trajectories by simultaneously fitting a multinomial logis- 84 
tic regression within the GBTM. 85 
Given the large number of baseline covariates, a selec- 86 
tion procedure was implemented. From the initial GBTM, 87 
each patient was assigned the trajectory corresponding to 88 
the highest membership probability. A multinomial logis- 89 
tic regression model was fit using stepwise selection, erring 90 
on the side of including more variables in the model. Fi- 91 
nally, the reduced set of baseline covariates was entered 92 
into the GBTM to fit the final model. Model results are 93 
reported using odds ratios (ORs) and 95% confidence in- 94 
tervals (CIs). 95 
The trajectory assignment was repeated for the final 96 
model to permit characterizing the trajectory patterns. 97 
Analysis of variance was conducted to test the differences 98 
in continuous variables, and Pearson χ2 tests were per- 99 
formed to test the independence of categorical variables 100 
in the 3 subgroups. Analyses were performed using SAS 101 
9.4. Results were considered significant at P < .05. The Q5 102 
health system’s institutional review board approved this 103 
study. 104 
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Table 1 
Number of Roux-en-Y gastric bypass patients with weight data at each 
Q6 
postsurgery year (N = 2918). 
Postsurgery 
year 
Frequency Total 
eligible 
Percent 
(N) 
Weight 
change % ∗
1 2399 2918 82.2 −31.1 (8.1) 
2 1738 2835 61.3 −31.2 (10.5) 
3 1714 2519 68.0 −28.7 (10.8) 
4 1455 2140 68.0 −26.9 (11.2) 
5 1244 1778 70.0 −25.5 (11.6) 
6 1049 1435 73.1 −24.6 (11.8) 
7 586 1019 57.5 −24.5 (12.0) 
∗ Weight change % from time of surgery. 
Fig. 1. Weight change trajectories in Roux-en-Y gastric bypass patients 
(N = 2918) up to 7 years postoperatively. 
Results 105 
Of 3215 possible eligible RYGB patients, 2918 patients 106 
(90.8%) had a weight in the EHR at postsurgery years 1 107 
through 7. Data available for analyses at each postoperative 108 
year are in Table 1 . At the time of surgery, patients were a 109 
mean age of 46.2 ± 11.2 years with a mean BMI of 46.9 110 
± 7.9 kg/m 2 . 111 
Weight change trajectories 112 
Through evaluation of the BIC criterion and visual fit, 3 Q7 113 
weight-change trajectories were best modeled with 2 quar- 114 
tic and 1 cubic polynomials ( Fig. 1 ). Group 1 (n = 818, 115 
28%) achieved a weight loss nadir of −42.85% ± 5.68% 116 
at 24 months postsurgery and −38.50% ± 7.37% weight 117 
loss at postsurgery year 7 (“above average” group). Group 118 
2 (n = 1307, 45%, “average” group) achieved a weight loss 119 
nadir of −31.57% ± 5.00% at 15 months postsurgery and 120 
−24.06% ± 7.48% weight change at postsurgery year 7. 121 
Group 3 (n = 793, 27%, “below average” group) achieved 122 
a weight loss nadir of −22.74% ± 5.66% at 12 months 123 
postsurgery and −12.67% ± 8.41% weight loss at post- 124 
surgery year 7. 125 
Mean percentage weight change for the above average 126 
group was −28.43% ± 5.69%; −24.38% ± 4.37% in the 127 
average group, and −20.13% ± 4.33% in the below aver- 128 
age group. 129 
Demographic characteristics 130 
Characteristics by trajectory group are in Table 2 . Com- 131 
pared with the above average group ( Table 3 ), patients 132 
in the below average group were more likely to be male 133 
(OR = 2.40, CI = 1.63–3.51, P < .001). 134 
Clinical characteristics 135 
Compared with the above average group, the below 136 
average group ( Table 3 ) had lower BMI at the time of 137 
surgery (OR = .91, CI = .90–.93, P < .0001). Below aver- 138 
age group patients were less likely to take sleep medica- 139 
tions (OR = .51, CI = .32–.81, P = .005) but more likely to 140 
have diabetes (noninsulin users, OR = 2.08, 1.46–2.96, P 141 
< .0001). 142 
No significant differences between trajectory groups 143 
were identified regarding number of medications or diag- 144 
noses of fibrosis, osteoarthritis, iron deficiency, sleep disor- 145 
ders, back or soft tissue disorders, or psychiatric disorders 146 
at the time of surgery ( P > .05, Table 3 ). 147 
Behavioral factors 148 
Below average group patients were less likely to smoke 149 
(OR = .62, CI = .47–.81, P = .0007). Mean preoperative 150 
and early postoperative weight changes by group are in 151 
Table 2 . No significant relationship was found between pre- 152 
operative weight change and postoperative weight trajec- 153 
tories ( P > .05). Smaller weight loss in the first 6 months 154 
postsurgery was associated with greater chance of a poorer 155 
long-term weight outcome (OR = 1.64, CI = 1.57–1.70, 156 
P < .0001). 157 
Discussion 158 
This study identified 3 distinct weight loss trajectories 159 
up to 7 years after RYGB. Our modeling resulted in fewer 160 
trajectories compared with a previous study that identified 161 
5 trajectories [1] , which is likely due to differing study 162 
durations, the data used, and statistical approaches. While 163 
almost half of our RYGB patients sustained a successful 164 
amount of weight at postoperative year 7 (25–30%), the 165 
remaining half equally either sustained an above average 166 
amount ( ≥40%) or a below average amount ( ≤20%) after 167 
reaching their weight loss nadir. 168 
Comparison of the demographic and clinical character- 169 
istics of the 2 most divergent weight loss outcomes (above 170 
average versus below average) led to the identification of 171 
several distinguishing characteristics. First, males were > 2 172 
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Table 2 
Demographic, clinical, and behavioral factors of Roux-en-Y gastric bypass patients by weight change trajectory group (N = 2918) ∗. 
Below average 
(n = 793) 
Average 
(n = 1307) 
Above average 
(n = 818) 
P value † 
Male sex, n (%) 176 (22.2) 260 (19.9) 133 (16.3) < .01 
Smoking history, n (%) 391 (49.3) 646 (49.4) 470 (57.5) < .001 
Age at surgery, yr, mean (SD) 48.7 (11.0) 45.5(11.0) 43.2 (10.9) < 0.0001 
BMI at surgery, kg/m 2 , mean (SD) 46.4 (7.9) 46.4 (7.8) 48.1 (7.9) < .0001 
Presurgical BMI change, kg/m 2 , mean (SD) −5.6 (5.1) −4.8 (5.3) −3.8 (5.7) < .0001 
Early postoperative weight change (0–6 mo %), 
mean (SD) 
−20.1 (4.3) −24.4 (4.4) −28.4 (5.1) < .0001 
Nondependent drug/alcohol use N (%) 31 (3.9) 76 (5.8) 69 (8.4) < .001 
Diabetes 373 (47.0%) 480 (36.7%) 223 (27.3%) < .001 
Hypertension 443 (55.9%) 654 (50.0%) 344 (42.0%) < .001 
Dyslipidemia 362 (45.7%) 538 (41.2%) 285 (34.8%) < .001 
Fibrosis, n (%) 223 (28.1) 339 (25.9) 214 (26.3) .52 
Iron deficiency, n (%) 107 (13.5) 170 (13.0) 96 (11.7) .54 
Osteoarthrosis and allied disorders 170 (21.4%) 305 (23.3%) 204 (24.9%) 0.25 
Disorders of the back 63 (7.9%) 136 (10.4%) 84 (10.3%) .15 
Soft tissue disorders 42 (5.3%) 71 (5.4%) 53 (6.5%) .51 
Depression 238 (30.0%) 351 (26.9%) 244 (29.8%) .19 
Sleep disorders 140 (17.7%) 224 (17.1%) 138 (16.9%) .91 
Any diabetes medication use 222 (28.0%) 244 (18.7%) 122 (14.9%) < .001 
Insulin use 145 (18.3%) 213 (16.3%) 92 (28.0%) < .001 
Bupropion 69 (8.7%) 108 (8.3%) 100 (12.2%) < .01 
Total medications ( > 12) 377 (47.5%) 588 (45.0%) 346 (42.3%) .11 
SD = standard deviation; BMI = body mass index. 
∗ At time of surgery unless otherwise noted. 
† Analysis of variance for continuous variables; χ2 test for categoric variables. 
Table 3 
Demographic, clinical, and behavioral factors associated with weight trajectory membership (N = 2918). 
Below average versus 
above average OR 
(95% CI) 
P value Average versus above 
average OR (95% CI) 
P value 
Age, yr 1.00 (.99–1.02) .81 1.01 (.99–1.02) .26 
Sex, male 2.40 (1.64–3.51) < .0001 .71 (.57–.89) .0003 
Smoking history, yes .62 (.47–.82) .0007 .71 (.57–.89) .003 
BMI, kg/m 2 (time of surgery) .91 (.90–.93) < .0001 .94 (.93–.95) < .0001 
Early postoperative weight 
change (0–6 mo, %) ∗
1.64 (1.57–1.70) < .0001 1.25 (1.21–1.28) < .0001 
Depressive disorder .98 (.72–1.33) .89 .80 (.63–1.03) .08 
Sleep medication .50 (0.31–.80) .005 .86 (.61–1.23) .43 
Diabetes, no insulin 2.08 (1.46–2.96) < .0001 1.44 (1.08–1.94) .02 
Diabetes, insulin 1.23 (.81–1.88) .33 1.28 (.90–1.81) .17 
OR = odds ratio; CI = confidence interval; BMI = body mass index. 
Adjusted results from group-based trajectory modeling. 
∗ Inverse relationship given that lower weight loss is associated with risk of below average group. 
times as likely to have below average outcomes. Though 173 
we had fewer males than females in our cohort, similar 174 
findings were reported in male gastric banding patients 175 
over aged ≥50 years [12] . Unlike previous studies, we did 176 
not find older age to be a risk factor for poorer weight loss 177 
[8,10,16] , which may relate to the long study timeframe. 178 
Future studies could evaluate sex and age in patients who 179 
undergo sleeve gastrectomy, a procedure that is rising in 180 
popularity. 181 
Second, patients with a higher BMI at the time of 182 
surgery were more likely to experience better BMI change 183 
over the study period, which mirrors the findings of several 184 
previous studies [21,22] . Higher BMI may be associated 185 
with greater co-morbidity, which may provide greater mo- 186 
tivation to adhere to the postoperative diet and lifestyle in 187 
the long term. However, other studies reported higher BMI 188 
to predict poorer weight loss, but these studies primar- 189 
ily used percentage excess weight loss to evaluate weight 190 
change, which is influenced by initial BMI [8,16,21] . 191 
Third, the use of certain medications was associated 192 
with weight change. Patients with diabetes who did not 193 
use insulin were > 2 times as likely to experience below 194 
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average weight loss. Notably, insulin use appeared to atten- 195 
uate this risk. This finding adds to the mixed findings on 196 
diabetes and long-term weight change after RYGB [8,16] . 197 
Patients using sleep medications were 50% less likely to 198 
experience poor trajectories. Patients using sleep medica- 199 
tions may be less likely to rise during the night, providing 200 
fewer opportunities for calorie consumption. Additionally, 201 
these patients could be more rested, providing greater mo- 202 
tivation to engage in healthy eating and lifestyle behav- 203 
iors. 204 
Several behavioral factors were evaluated in regard to 205 
weight outcomes, including preoperative and early postop- 206 
erative weight loss and smoking history. We did not find a 207 
relationship between preoperative weight change and post- 208 
operative weight outcomes. A previous prospective, ran- 209 
domized trial found patients in a preoperative program with 210 
the goal of 10% weight loss achieved greater percentage 211 
excess weight loss at 3 months postsurgery compared with 212 
controls with no preoperative weight loss expectation [23] . 213 
Physician-supervised preoperative weight loss is strongly 214 
recommended, if not required, as a prerequisite to surgery 215 
in many programs [24] ; however, our findings do not sup- 216 
port the clinical relevance of this recommendation as it 217 
relates to a patient’s ability and readiness to implement be- 218 
havior change. Additional prospective, randomized studies 219 
are needed to investigate the direction of the potential re- 220 
lationship between preoperative weight loss and long-term 221 
outcomes. 222 
In our study, greater weight loss within the initial 6 post- 223 
operative months decreased the likelihood of poorer weight 224 
outcomes. Manning et al. [18] also found initial weight loss 225 
velocity after RYGB to predict better weight loss. Collec- 226 
tively, our findings suggest that clinically, this initial period 227 
of rapid weight loss may be a target for future interven- 228 
tions. While diet during the first 3 postoperative months is 229 
largely dictated by the staged dietary progression [25] , pa- 230 
tients can exert more choice regarding level of adherence 231 
to the recommended long-term diet during postoperative 232 
months 3 to 6. Future studies could evaluate the impact 233 
of additional behavioral support during this critical weight 234 
loss time on dietary adherence and long-term weight out- 235 
comes. Finally, patients with a history of smoking were 236 
less likely to have below average long-term weight loss 237 
(38%). A history of smoking may be protective in that 238 
patients may be able to apply the experience and skills 239 
gained to achieve smoking cessation to behavior change 240 
for long-term weight reduction. 241 
Our study had several strengths, including the long time- 242 
frame for some patients, the inclusion of all available 243 
weight data from the EHR, and the wide range of demo- 244 
graphic, behavioral, and clinical factors explored in relation 245 
to weight trajectories. Our study was limited, however, by 246 
the retrospective design, homogeneity of our cohort, fewer 247 
patients for inclusion at the later postoperative years, and 248 
the inclusion of only 1 procedure type (RYGB). 249 
Conclusion 250 
In summary, certain RYGB patients may be at risk for 251 
less robust long-weight loss. These patients, however, still Q8 252 
lose clinically meaningful amounts of weight and may ex- 253 
perience the other well-documented benefits of surgery, 254 
such as improvements in co-morbid conditions and qual- 255 
ity of life [3–5,26] . Study findings can help to inform 256 
patient–provider discussions surrounding postoperative ex- 257 
pectations after RYGB and better guide clinical care. 258 
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